Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Chen IS
,
Liu C
,
Tateyama M
,
Karbat I
,
Uesugi M
,
Reuveny E
,
Kubo Y
.
???displayArticle.abstract???
BACKGROUND AND PURPOSE: A second-generation antihistamine, terfenadine, is known to induce arrhythmia by blocking hERG channels. In this study, we have shown that terfenadine also inhibits the activity of G-protein-gated inwardly rectifying K+ (GIRK) channels, which regulate the excitability of neurons and cardiomyocytes. To clarify the underlying mechanism(s), we examined the effects of several antihistamines on GIRK channels and identified the structural determinant for the inhibition.
EXPERIMENTAL APPROACH: Electrophysiological recordings were made in Xenopus oocytes and rat atrial myocytes to analyse the effects of antihistamines on various GIRK subunits (Kir 3.x). Mutagenesis analyses identified the residues critical for inhibition by terfenadine and the regulation of ion selectivity. The potential docking site of terfenadine was analysed by molecular docking.
KEY RESULTS: GIRK channels containing Kir 3.1 subunits heterologously expressed in oocytes and native GIRK channels in atrial myocytes were inhibited by terfenadine and other non-sedating antihistamines. In Kir 3.1 subunits, mutation of Phe137, located in the centre of the pore helix, to the corresponding Ser in Kir 3.2 subunits reduced the inhibition by terfenadine. Introduction of an amino acid with a large side chain in Kir 3.2 subunits at Ser148 increased the inhibition. When this residue was mutated to a non-polar amino acid, the channel became permeable to Na+ . Phosphoinositide-mediated activity was also decreased by terfenadine.
CONCLUSION AND IMPLICATIONS: The Phe137 residue in Kir 3.1 subunits is critical for inhibition by terfenadine. This study provides novel insights into the regulation of GIRK channels by the pore helix and information for drug design.
Adney,
A Critical Gating Switch at a Modulatory Site in Neuronal Kir3 Channels.
2015, Pubmed,
Xenbase
Adney,
A Critical Gating Switch at a Modulatory Site in Neuronal Kir3 Channels.
2015,
Pubmed
,
Xenbase
Alexander,
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Voltage-gated ion channels.
2017,
Pubmed
Alexander,
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors.
2017,
Pubmed
Benavides,
In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.
1995,
Pubmed
Chan,
Control of channel activity through a unique amino acid residue of a G protein-gated inwardly rectifying K+ channel subunit.
1996,
Pubmed
,
Xenbase
Chen,
MolProbity: all-atom structure validation for macromolecular crystallography.
2010,
Pubmed
Chen,
RGS4 regulates partial agonism of the M2 muscarinic receptor-activated K+ currents.
2014,
Pubmed
,
Xenbase
Chen,
Ivermectin activates GIRK channels in a PIP2 -dependent, Gβγ -independent manner and an amino acid residue at the slide helix governs the activation.
2017,
Pubmed
,
Xenbase
Chen,
Structural determinants at the M2 muscarinic receptor modulate the RGS4-GIRK response to pilocarpine by impairment of the receptor voltage sensitivity.
2017,
Pubmed
,
Xenbase
Chen,
Non-sedating antihistamines block G-protein-gated inwardly rectifying K<sup>+</sup> channels.
2020,
Pubmed
,
Xenbase
Clapham,
New roles for G-protein beta gamma-dimers in transmembrane signalling.
1993,
Pubmed
Crumb,
Loratadine blockade of K(+) channels in human heart: comparison with terfenadine under physiological conditions.
2000,
Pubmed
Curtis,
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers.
2018,
Pubmed
Dobrev,
The G protein-gated potassium current I(K,ACh) is constitutively active in patients with chronic atrial fibrillation.
2005,
Pubmed
Doupnik,
Venom-derived peptides inhibiting Kir channels: Past, present, and future.
2017,
Pubmed
Fernandez,
Physicochemical features of the HERG channel drug binding site.
2004,
Pubmed
,
Xenbase
Gottlieb,
Antihistamine drug withdrawn by manufacturer.
1999,
Pubmed
Grantham,
Amino acid difference formula to help explain protein evolution.
1974,
Pubmed
Grosdidier,
SwissDock, a protein-small molecule docking web service based on EADock DSS.
2011,
Pubmed
Harding,
The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY.
2018,
Pubmed
Hey,
Antihistamine activity, central nervous system and cardiovascular profiles of histamine H1 antagonists: comparative studies with loratadine, terfenadine and sedating antihistamines in guinea-pigs.
1995,
Pubmed
Hibino,
Inwardly rectifying potassium channels: their structure, function, and physiological roles.
2010,
Pubmed
Hindmarch,
The acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flare.
2001,
Pubmed
Holgate,
Consensus Group on New-Generation Antihistamines (CONGA): present status and recommendations.
2003,
Pubmed
Inanobe,
Kir Channel Blockages by Proflavine Derivatives via Multiple Modes of Interaction.
2018,
Pubmed
Jackman,
Ventricular tachyarrhythmias in the long QT syndromes.
1984,
Pubmed
Jin,
Synthesis of a stable form of tertiapin: a high-affinity inhibitor for inward-rectifier K+ channels.
1999,
Pubmed
,
Xenbase
June,
Torsades de pointes with terfenadine ingestion.
1997,
Pubmed
Kamiya,
Molecular determinants of hERG channel block by terfenadine and cisapride.
2008,
Pubmed
,
Xenbase
Kawada,
Isolation of proflavine as a blocker of G protein-gated inward rectifier potassium channels by a cell growth-based screening system.
2016,
Pubmed
,
Xenbase
Kilkenny,
Animal research: reporting in vivo experiments: the ARRIVE guidelines.
2010,
Pubmed
Kobayashi,
Ethanol opens G-protein-activated inwardly rectifying K+ channels.
1999,
Pubmed
,
Xenbase
Kofuji,
A unique P-region residue is required for slow voltage-dependent gating of a G protein-activated inward rectifier K+ channel expressed in Xenopus oocytes.
1996,
Pubmed
,
Xenbase
Krapivinsky,
The G-protein-gated atrial K+ channel IKACh is a heteromultimer of two inwardly rectifying K(+)-channel proteins.
1995,
Pubmed
,
Xenbase
Kubo,
Primary structure and functional expression of a rat G-protein-coupled muscarinic potassium channel.
1993,
Pubmed
,
Xenbase
Kubo,
Identification of domains of the cardiac inward rectifying K+ channel, CIR, involved in the heteromultimer formation and in the G-protein gating.
1996,
Pubmed
,
Xenbase
Kurachi,
Short-term desensitization of muscarinic K+ channel current in isolated atrial myocytes and possible role of GTP-binding proteins.
1987,
Pubmed
Lesage,
Cloning provides evidence for a family of inward rectifier and G-protein coupled K+ channels in the brain.
1994,
Pubmed
,
Xenbase
Liao,
Heteromultimerization of G-protein-gated inwardly rectifying K+ channel proteins GIRK1 and GIRK2 and their altered expression in weaver brain.
1996,
Pubmed
Logothetis,
The beta gamma subunits of GTP-binding proteins activate the muscarinic K+ channel in heart.
,
Pubmed
Marker,
Spinal G-protein-gated K+ channels formed by GIRK1 and GIRK2 subunits modulate thermal nociception and contribute to morphine analgesia.
2004,
Pubmed
Masotti,
Keppen-Lubinsky syndrome is caused by mutations in the inwardly rectifying K+ channel encoded by KCNJ6.
2015,
Pubmed
McGrath,
Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP.
2015,
Pubmed
Merlos,
Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
1997,
Pubmed
Monahan,
Torsades de pointes occurring in association with terfenadine use.
1990,
Pubmed
Murata,
Phosphoinositide phosphatase activity coupled to an intrinsic voltage sensor.
2005,
Pubmed
,
Xenbase
Myokai,
Topological mapping of the asymmetric drug binding to the human ether-à-go-go-related gene product (HERG) potassium channel by use of tandem dimers.
2008,
Pubmed
,
Xenbase
Nishio,
Blockage by terfenadine of the adenosine triphosphate (ATP)-sensitive K+ current in rabbit ventricular myocytes.
1998,
Pubmed
Paris,
Torsades de pointes induced by erythromycin and terfenadine.
1994,
Pubmed
Patil,
A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation.
1995,
Pubmed
Pettersen,
UCSF Chimera--a visualization system for exploratory research and analysis.
2004,
Pubmed
Pratt,
Cardiovascular safety of fexofenadine HCl.
1999,
Pubmed
Reuveny,
Activation of the cloned muscarinic potassium channel by G protein beta gamma subunits.
1994,
Pubmed
,
Xenbase
Sadja,
Coupling Gbetagamma-dependent activation to channel opening via pore elements in inwardly rectifying potassium channels.
2001,
Pubmed
,
Xenbase
Silverman,
Asymmetrical contributions of subunit pore regions to ion selectivity in an inward rectifier K+ channel.
1998,
Pubmed
,
Xenbase
Simons,
H1 antihistamines: current status and future directions.
2008,
Pubmed
Slesinger,
Ion selectivity filter regulates local anesthetic inhibition of G-protein-gated inwardly rectifying K+ channels.
2001,
Pubmed
,
Xenbase
Studer,
Assessing the local structural quality of transmembrane protein models using statistical potentials (QMEANBrane).
2014,
Pubmed
Taglialatela,
Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity.
1999,
Pubmed
Taglialatela,
Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines.
1998,
Pubmed
,
Xenbase
Tateyama,
Gi/o-coupled muscarinic receptors co-localize with GIRK channel for efficient channel activation.
2018,
Pubmed
Terrien,
Comparison of the effects of terfenadine with fexofenadine on nasal provocation tests with allergen.
1999,
Pubmed
Wang,
Cryo-EM Structure of the Open Human Ether-à-go-go-Related K+ Channel hERG.
2017,
Pubmed
Waterhouse,
SWISS-MODEL: homology modelling of protein structures and complexes.
2018,
Pubmed
Weber,
Ion currents of Xenopus laevis oocytes: state of the art.
1999,
Pubmed
,
Xenbase
Whorton,
Crystal structure of the mammalian GIRK2 K+ channel and gating regulation by G proteins, PIP2, and sodium.
2011,
Pubmed
,
Xenbase
Whorton,
X-ray structure of the mammalian GIRK2-βγ G-protein complex.
2013,
Pubmed
Wilkins,
Protein identification and analysis tools in the ExPASy server.
1999,
Pubmed
Wishart,
DrugBank: a comprehensive resource for in silico drug discovery and exploration.
2006,
Pubmed
Woodward,
Terfenadine, the first non-sedating antihistamine.
1982,
Pubmed
Zagotta,
Membrane biology: permutations of permeability.
2006,
Pubmed
